These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35638851)

  • 21. Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug delivery.
    Zhu Y; Wang L; Li Y; Huang Z; Luo S; He Y; Han H; Raza F; Wu J; Ge L
    Biomater Sci; 2020 Oct; 8(19):5415-5426. PubMed ID: 32996920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells.
    Muhammad N; Zhao H; Song W; Gu M; Li Q; Liu Y; Li C; Wang J; Zhan H
    Nanotechnology; 2021 Feb; 32(8):085105. PubMed ID: 33197899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
    Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
    Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
    Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy.
    Nguyen A; Chao PH; Ong CY; Rouhollahi E; Fayez NA; Lin L; Brown JI; Böttger R; Page B; Wong H; Li SD
    Biomaterials; 2022 Oct; 289():121735. PubMed ID: 36055815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.
    Li M; Shi K; Tang X; Wei J; Cun X; Long Y; Zhang Z; He Q
    Nanomedicine; 2018 Aug; 14(6):1833-1843. PubMed ID: 29800759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor.
    Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G
    J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete regression of xenografted breast tumors by dextran-based dual drug conjugates containing paclitaxel and docosahexaenoic acid.
    Wang S; Liu J; Lv H; Huang X; Dong P; Wang Q; Yang H; Wang S; Li X; Hu J; Wang D; Cao S; Xie L; Shi Y
    Eur J Med Chem; 2022 Oct; 240():114567. PubMed ID: 35779290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery.
    Jin S; Wan J; Meng L; Huang X; Guo J; Liu L; Wang C
    ACS Appl Mater Interfaces; 2015 Sep; 7(35):19843-52. PubMed ID: 26288386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
    He R; Yin C
    Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assembly of pH-Responsive Antibody-Drug-Inspired Conjugates.
    Raabe M; Heck AJ; Führer S; Schauenburg D; Pieszka M; Wang T; Zegota MM; Nuhn L; Ng DYW; Kuan SL; Weil T
    Macromol Biosci; 2022 Feb; 22(2):e2100299. PubMed ID: 34791790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperatively Responsive Peptide Nanotherapeutic that Regulates Angiopoietin Receptor Tie2 Activity in Tumor Microenvironment To Prevent Breast Tumor Relapse after Chemotherapy.
    Zhang L; Qi Y; Min H; Ni C; Wang F; Wang B; Qin H; Zhang Y; Liu G; Qin Y; Duan X; Li F; Han X; Tao N; Zhang L; Qin Z; Zhao Y; Nie G
    ACS Nano; 2019 May; 13(5):5091-5102. PubMed ID: 30986342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH- and Enzyme-Sensitive IR820-Paclitaxel Conjugate Self-Assembled Nanovehicles for Near-Infrared Fluorescence Imaging-Guided Chemo-Photothermal Therapy.
    Zhang D; Zhang J; Li Q; Tian H; Zhang N; Li Z; Luan Y
    ACS Appl Mater Interfaces; 2018 Sep; 10(36):30092-30102. PubMed ID: 30118198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
    Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
    J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
    Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
    J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy.
    Xiao Y; Wang S; Zong Q; Yin Z
    AAPS PharmSciTech; 2018 Jul; 19(5):2395-2406. PubMed ID: 29869309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.